CHK.AX stock is trading at A$0.005, up 66.67% intraday on 28 Feb 2026, driven by a 35,069,450 share volume surge that marks it as a high-volume mover on the ASX. The stock opened at A$0.004, hit a day high of A$0.006, and rose from a previous close of A$0.003. Average daily volume sits at 3,094,749, so today’s turnover is more than ten times normal. We summarise what the numbers mean for traders and investors watching Cohiba Minerals Limited (CHK.AX) in Australia.

CHK.AX stock intraday snapshot

CHK.AX stock shows a sharp intraday move to A$0.005, a +0.002 change from the previous close. The session range is A$0.004–A$0.006, with a 52-week range of A$0.0015–A$0.007. Market capitalisation is A$21,482,900 and shares outstanding are 4,296,580,096. Relative volume is 11.33, signalling abnormal trading interest and potential short-term volatility.

Catalysts and CHK.AX stock news

There is no company earnings release in today’s feed, so the volume spike looks driven by market speculation around exploration updates, retail flow, or research commentary. Traders should check the company site and official ASX notices before acting. See Cohiba Minerals Limited filings and company details on the corporate site and ASX source and ASX company page.

Fundamentals and valuation for CHK.AX stock

Cohiba Minerals operates in Basic Materials with projects in Western Australia and South Australia. Financials show negative net income per share -A$0.00210 and limited operating cash flow. Price-to-book is 0.85, book value per share is A$0.00586, and cash per share is A$0.00104. The company has no reported EPS or dividends. These figures indicate an early-stage explorer profile with valuation tied to resource news rather than earnings multiples.

Technicals, volume and price targets

Price is trading above the 50-day average A$0.00313 and 200-day average A$0.00280, which supports a short-term bullish technical read. High relative volume of 11.33 increases momentum but also downside risk. Near-term technical resistance sits at the 52-week high A$0.007. We set practical intraday targets: a conservative target A$0.008 (implied +60.00%) and an optimistic target A$0.010 (implied +100.00%). A protective stop could sit at A$0.003 (implied -40.00%).

Meyka AI grade and sector context

Meyka AI rates CHK.AX with a score out of 100: 58.64 | Grade: C+ | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Cohiba sits in the Basic Materials sector, which has shown YTD performance +9.92%; sector tailwinds for explorers can lift microcap names, but risks remain.

Risks and catalysts to monitor for CHK.AX stock

Key risks include cash burn, share dilution given 4.30 billion shares outstanding, low liquidity outside today’s spike, and the speculative nature of exploration-stage assets. Catalysts that would validate gains include an ASX announcement of drilling results, binding JV interest, or a funding update. Watch formal ASX releases and broker notes for confirmed drivers.

Final Thoughts

CHK.AX stock is an intraday high-volume mover trading at A$0.005 on 28 Feb 2026, with a +66.67% price change and 35,069,450 shares traded. The jump leaves the stock above both the 50- and 200-day averages, but fundamentals show negative earnings and small cash buffers. Meyka AI’s forecast model projects A$0.009 over a 12-month horizon, implying an +80.00% upside from the current price. Forecasts are model-based projections and not guarantees. Traders should treat today as a liquidity window: confirm any official ASX announcements, size positions for high volatility, and consider targets near A$0.008–A$0.010 with stops around A$0.003. As an AI-powered market analysis platform, Meyka AI flags CHK.AX for monitoring, not as investment advice. Always perform your own due diligence before trading.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.